Cleared Traditional

K213751 - NextAR TKA Platform My Knee PPS

K213751 is the FDA 510(k) clearance for NextAR TKA Platform My Knee PPS by Medacta International S.A.. It is a Class 2 Orthopedic device (product code SBF) cleared through the Traditional 510(k) pathway after a 100-day FDA review.

K213751 · Medacta International S.A. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2022
Decision
100d
Days
Class 2
Risk

K213751 is an FDA 510(k) clearance for the NextAR™ TKA Platform My Knee PPS. Classified as Orthopedic Augmented Reality (product code SBF), Class II - Special Controls.

Submitted by Medacta International S.A. (Castel San Pietro (Ch), CH). The FDA issued a Cleared decision on March 10, 2022 after a review of 100 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 882.4560 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Medacta International S.A. devices

Submission Details

510(k) Number K213751 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 30, 2021
Decision Date March 10, 2022
Days to Decision 100 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 122d · This submission: 100d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code SBF Orthopedic Augmented Reality
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
Definition An Orthopedic Augmented Reality Device Provides Visual Guidance During Orthopedic Procedures, Where The Use Of Stereotaxic Navigation Is Utilized. Visual Guidance Is Displayed As “augmented Reality” Stereoscopic Images To Intraoperatively Augment The User’s Field Of View.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Medacta USA
Chris Lussier

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - SBF Orthopedic Augmented Reality

All 41
Devices cleared under the same product code (SBF) and FDA review panel - the closest regulatory comparables to K213751.
SpineAR SNAP
K213034 · Surgical Theater, Inc. · Sep 2022
Knee+
K220104 · Pixee Medical · Sep 2022
OptiVu ROSA MxR
K220733 · Orthosoft Inc. (d/b/a) Zimmer CAS · Jul 2022
ARAI Surgical Navigation System
K211254 · Surgalign Spine Technologies · Jan 2022
NextAR™ Spine Platform
K210859 · Medacta International S.A. · Nov 2021
xvision Spine system (XVS)
K211188 · Augmedics, Ltd. · Jul 2021